EXICURE, INC. cotiza a 1.09 USD y tiene una capitalización bursátil de $7M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeu…
| Periodo | 2022-08 | 2022-05 | 2022-03 | 2021-11 |
|---|---|---|---|---|
| Real | $-8.30 | $-10.50 | $-22.50 | $-40.50 |
| Estimado | $-6.00 | $-10.50 | $-21.00 | $-22.50 |
| Sorpresa | -38.3% | +0.0% | -7.1% | -80.0% |
| Métrica | XCUR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -126.0% | -40.4% | -85.6% |
| ROA | -35.2% | -32.0% | -3.2% |
| Current Ratio | 1.19 | 2.84 | -1.65 |
| Debt / Equity | — | 0.28 | — |